189 related articles for article (PubMed ID: 32114594)
1. Immunohistochemistry of mammary Paget's disease. Cytokeratin 7, GATA3, and HER2 are sensitive markers.
Arain SA; Arafah M; Said Raddaoui EM; Tulba A; Alkhawaja FH; Al Shedoukhy A
Saudi Med J; 2020 Mar; 41(3):232-237. PubMed ID: 32114594
[TBL] [Abstract][Full Text] [Related]
2. Molecular subtyping of mammary Paget's disease using immunohistochemistry.
Arafah M; Arain SA; Raddaoui EMS; Tulba A; Alkhawaja FH; Al Shedoukhy A
Saudi Med J; 2019 May; 40(5):440-446. PubMed ID: 31056619
[TBL] [Abstract][Full Text] [Related]
3. Not All Cases of Mammary Paget's Disease are Cytokeratin-7 Positive: A Challenging Diagnosis!
Anja K; Hélène D; Pascal VE; Liliane M; Mieke VB
Int J Surg Pathol; 2021 Sep; 29(6):631-634. PubMed ID: 33750236
[TBL] [Abstract][Full Text] [Related]
4. Cytokeratin 7-negative mammary Paget's disease: A diagnostic pitfall.
Ozerdem U; McNiff JM; Tavassoli FA
Pathol Res Pract; 2016 Apr; 212(4):279-81. PubMed ID: 26944832
[TBL] [Abstract][Full Text] [Related]
5. Useful immunohistochemical markers for distinguishing Paget cells from Toker cells.
Park S; Suh YL
Pathology; 2009; 41(7):640-4. PubMed ID: 20001343
[TBL] [Abstract][Full Text] [Related]
6. Different panels of markers should be used to predict mammary Paget's disease associated with in situ or invasive ductal carcinoma of the breast.
Lester T; Wang J; Bourne P; Yang Q; Fu L; Tang P
Ann Clin Lab Sci; 2009; 39(1):17-24. PubMed ID: 19201736
[TBL] [Abstract][Full Text] [Related]
7. Transcriptome analyses reveal FOXA1 dysregulation in mammary and extramammary Paget's disease.
Mai R; Zhou S; Zhou S; Zhong W; Hong L; Wang Y; Lu S; Pan J; Huang Y; Su M; Crawford R; Zhou Y; Zhang G
Hum Pathol; 2018 Jul; 77():152-158. PubMed ID: 29630912
[TBL] [Abstract][Full Text] [Related]
8. Toker cells of the breast. Morphological and immunohistochemical characterization of 40 cases.
Di Tommaso L; Franchi G; Destro A; Broglia F; Minuti F; Rahal D; Roncalli M
Hum Pathol; 2008 Sep; 39(9):1295-300. PubMed ID: 18614197
[TBL] [Abstract][Full Text] [Related]
9. Intraepidermal cytokeratin 7 expression is not restricted to Paget cells but is also seen in Toker cells and Merkel cells.
Lundquist K; Kohler S; Rouse RV
Am J Surg Pathol; 1999 Feb; 23(2):212-9. PubMed ID: 9989849
[TBL] [Abstract][Full Text] [Related]
10. Mammary Paget's disease and extra-mammary Paget's disease: two morphologically similar but biologically different diseases.
Liu W; Iqbal J; Khoury T
J Cutan Pathol; 2010 Nov; 37(11):1145-9. PubMed ID: 19719834
[TBL] [Abstract][Full Text] [Related]
11. Intraepidermal cytokeratin 7 immunoreactive cells in the non-neoplastic nipple may represent interepithelial extension of lactiferous duct cells.
Yao DX; Hoda SA; Chiu A; Ying L; Rosen PP
Histopathology; 2002 Mar; 40(3):230-6. PubMed ID: 11895488
[TBL] [Abstract][Full Text] [Related]
12. Minimally invasive mammary Paget's disease without an underlying breast carcinoma.
Hanna M; Jaffer S; Bleiweiss IJ; Nayak A
Virchows Arch; 2013 Sep; 463(3):471-3. PubMed ID: 23851623
[No Abstract] [Full Text] [Related]
13. Routine diagnosis of mammary Paget's disease. A modern approach.
Hitchcock A; Topham S; Bell J; Gullick W; Elston CW; Ellis IO
Am J Surg Pathol; 1992 Jan; 16(1):58-61. PubMed ID: 1370192
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the biomarkers for targeted therapies in primary extra-mammary and mammary Paget's disease.
Gatalica Z; Vranic S; Krušlin B; Poorman K; Stafford P; Kacerovska D; Senarathne W; Florento E; Contreras E; Leary A; Choi A; In GK
Cancer Med; 2020 Feb; 9(4):1441-1450. PubMed ID: 31899853
[TBL] [Abstract][Full Text] [Related]
15. Mammary Paget's Disease of the Male Breast: A Rare Case With an Unusual Immunohistochemical Profile.
Moore SA; Notgrass HM; Vandergriff TW; Sahoo S
Int J Surg Pathol; 2020 Apr; 28(2):210-215. PubMed ID: 31514589
[TBL] [Abstract][Full Text] [Related]
16. Apocrine gland carcinoma of the mammary skin concomitant with pagetoid phenomenon.
Usui K; Ochiai T; Abe I; Nishio H; Togo K; Yamagata M
J Dermatol; 2010 Apr; 37(4):350-4. PubMed ID: 20507405
[TBL] [Abstract][Full Text] [Related]
17. Cutaneous and mammary apocrine carcinomas have different immunoprofiles.
Piris A; Peng Y; Boussahmain C; Essary LR; Gudewicz TM; Hoang MP
Hum Pathol; 2014 Feb; 45(2):320-6. PubMed ID: 24342430
[TBL] [Abstract][Full Text] [Related]
18. Cytokeratin 7-negative and GATA binding protein 3-negative breast cancers: Clinicopathological features and prognostic significance.
Lu S; Yakirevich E; Wang LJ; Resnick MB; Wang Y
BMC Cancer; 2019 Nov; 19(1):1085. PubMed ID: 31718619
[TBL] [Abstract][Full Text] [Related]
19. Paget's disease of the nipple in a Her2-positive breast cancer xenograft model.
Drews-Elger K; Sandoval-Leon AC; Ergonul AB; Jegg AM; Gomez-Fernandez C; Miller PC; El-Ashry D; Lippman ME
Breast Cancer Res Treat; 2020 Feb; 179(3):577-584. PubMed ID: 31720992
[TBL] [Abstract][Full Text] [Related]
20. Characterisation of GATA3 expression in invasive breast cancer: differences in histological subtypes and immunohistochemically defined molecular subtypes.
Shaoxian T; Baohua Y; Xiaoli X; Yufan C; Xiaoyu T; Hongfen L; Rui B; Xiangjie S; Ruohong S; Wentao Y
J Clin Pathol; 2017 Nov; 70(11):926-934. PubMed ID: 28428285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
